Search results for: 'sic plan semiconductor school drug'
- Related search terms
- drug discovery ad earth development outsourcing market
- drug discovery ad east development outsourcing market
- plant 01 00 00 00
- plan services market global 2024 2024
- plant services market global 2024 2024
-
13 Jul 2023  |  North America  |  Market Research
Strategic Opportunities in the Global School Bus Market
A Recovering Demand and Ongoing Electrification Efforts Bolster Growth
This Frost & Sullivan report on the global school bus industry provides an in-depth analysis of the growth environment, global trends, and an extensive examination of the school bus space segmented by region. The global school bus industry is expected to grow at a 4.1% rate as market demand experiences a rebound after the pandemic, with replacemen...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Mar 2023  |  North America  |  Market Research
Strategic Analysis of WBG Semiconductors in Power Electronics Applications for EVs, Forecast to 2030
Future Growth Potential of Semiconductor Industry With Growing Powertrain Electrification to Improve Power Density and Efficiency
The increasing use of electric vehicles (EVs) worldwide boosts power semiconductor demand. Government laws and subsidies, original equipment manufacturers' (OEMs') dedication to net zero emissions, and sustainability goals accelerate EV penetration in the vehicle industry. This study focuses on wide bandgap (WBG) semiconductors for the North Americ...
$4,950.00
Special Price $3,712.50 save 25 %
-
09 Dec 2025  |  North America  |  Frost Radar
Frost Radar™: School Bus Manufacturers in North America, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Frost & Sullivan expects North America’s school bus market to experience steady, multiyear, replacement-driven growth, supported by an aging national fleet, rising safety requirements, and expanding state-level investment in clean student transportation. While established manufacturers continue to dominate in production scale, dealer reach, and mul...
$4,950.00 -
22 Jan 2015  |  North America  |  Market Research
A Product and Pipeline Analysis of the Antibacterial Drugs Market
Regulatory Approaches to Combat Microbial Resistance and Stimulate Antibiotics R&D
Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...
$3,950.00
Special Price $2,962.50 save 25 %
-
21 Feb 2019  |  North America  |  Market Research
Global School Bus Market Analysis, Forecast to 2025
School Bus Market is Poised to Reach 109,000 Units Globally by 2025, Driven by the Demand for Safe Transport of Children; Supporting Telematics Services will also see a Surge in Adoption
The demand for school buses globally is expected to grow steadily despite rising oil and commodity prices. Total school bus shipments, estimated at about 92,561 units in 2017, are expected to increase to 109,575 units in 2025, reflecting a compound annual growth rate (CAGR) of 2.1%. North America is the largest contributor to the global school bus ...
$4,950.00
Special Price $3,712.50 save 25 %
-
20 Feb 2024  |  North America  |  Market Research
Growth Opportunities in Drug Discovery and Early Development Outsourcing Services
M&As, Partnerships, and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion
The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....
$4,950.00
Special Price $3,712.50 save 25 %
-
01 Mar 2024  |  North America  |  Market Research
Global Orphan Drug Growth Opportunities
Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions
In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...
$4,950.00
Special Price $3,712.50 save 25 %
-
11 Nov 2016  |  North America  |  Market Research
Global Orphan Drug Market
High Pricing and Undefined Reimbursement Policies will Limit the Sales of Orphan Drugs
The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...
$6,000.00
Special Price $4,500.00 save 25 %
-
29 Dec 2017  |  North America  |  Technology Research
Innovations in Transdermal Drug Delivery
Microneedle Technologies Creating Novel Opportunities in Transdermal Drug Delivery Industry
With the healthcare industry moving toward patient convenience and comfort, pharmaceutical and medical device companies are continuously researching for the most effective, side effect free, convenient route of drug delivery. Transdermal drug delivery is a painless method of delivering drug formulation. Transdermal route of drug administration has ...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Aug 2020  |  North America  |  Market Research
New Drug Development for Rare Pediatric Disorders Sustaining High Growth in the Global Orphan Drugs Market, 2019–2025
AI-powered Early Disease Diagnosis and Drug Repurposing will Create New Growth Opportunities
Rare diseases have been an increasing area of focus as three waves have converged in recent years: genomic research and innovations becoming mainstream; the forthcoming regulatory policies and financial incentives put in place by the federal agencies; and the increasingly patient-centric and coordinated efforts of patient advocacy groups, caregive...
$4,950.00
Special Price $3,712.50 save 25 %